Impact of a Trump Administration on FDA and Biotech

This chapter examines the potential effects of a Trump presidency on the FDA and the healthcare landscape, particularly through the lens of Robert F. Kennedy Jr.'s influence and criticism of regulatory agencies. It discusses concerns around user fees, the stability of FDA appointments, and the balance between regulatory independence and industry influence. The chapter also highlights the implications of political shifts on investor sentiment and the overall dynamics of the biotech industry.